ST AIA-PACK PA

Prostate-specific Antigen (psa) For Management Of Prostate Cancers

FDA Premarket Approval P910065 S001

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for the aia-pack pa. The device is designed for in vitro diagnostic use only for the quantitative measurement of prostate specific antigen (psa) in human serum on tosoh aia system analyzers. This device is indicated for the measurement of serum psa in conjunction with digital rectal examination (dre) as an aid in the detection of prostate cancer (cap) in men fifty years of age and older. Prostate biopsy is required for the diagnosis of cancer. The device is further indicated for the serial measurement of psa in human serum to be used as an aid in the management of patients with prostatic cancer.

DeviceST AIA-PACK PA
Classification NameProstate-specific Antigen (psa) For Management Of Prostate Cancers
Generic NameProstate-specific Antigen (psa) For Management Of Prostate Cancers
ApplicantTOSOH BIOSCIENCE, INC.
Date Received1999-03-25
Decision Date1999-09-10
Notice Date2000-09-21
PMAP910065
SupplementS001
Product CodeLTJ
Docket Number00M-1523
Advisory CommitteeImmunology
Supplement TypePanel Track
Supplement ReasonLabeling Change - Indications/instructions/shelf Life/tradename
Expedited ReviewNo
Combination Product No
Applicant Address TOSOH BIOSCIENCE, INC. 6000 Shoreline Court suite 101 south San Francisco, CA 94080
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P910065Original Filing
S009 2019-05-20 Special (immediate Track)
S008 2011-03-30 Normal 180 Day Track
S007 2009-04-24 Normal 180 Day Track
S006 2005-06-06 Normal 180 Day Track
S005 2004-04-07 Normal 180 Day Track
S004 2003-06-04 Normal 180 Day Track
S003 2002-01-09 Normal 180 Day Track
S002 1999-12-16 Normal 180 Day Track
S001 1999-03-25 Panel Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.